Abstract
Homozygous familial hypercholesterolaemia (FH) is an autosomal-dominant inherited disease presenting with highly elevated low-density lipoprotein cholesterol (LDL-C) levels. Untreated, the patient can develop atherosclerosis and cardiovascular disease already in adolescence. Treatment with statins and ezetimibe is usually not sufficient and LDL apheresis is often required. Lomitapide, an inhibitor of the microsomal triglyceride transfer protein, reduces LDL-C and triglyceride levels and can be used alone or in combination with other therapies in homozygous FH. However, experience with this agent is still limited. We present a young female who was diagnosed with homozygous FH at 6 years of age. She shows a complete lack of normal LDL receptor activity and no cholesterol-lowering effect from statins. The patient was treated with LDL apheresis from 7 years of age. When LDL apheresis treatment extended to twice a week, she began to experience adverse effects, including catheter-related complications, infections, and hospital admissions. When lomitapide treatment was initiated, the frequency of apheresis reduced, the LDL-C levels improved and she has not had any further hospital admissions since. Initially, she suffered from gastroi...Continue Reading
References
Sep 1, 1989·The Journal of Clinical Investigation·M ErikssonB Angelin
Dec 6, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Suzanne LindBo Angelin
Dec 31, 2003·Ultrasound in Medicine & Biology·Laurent SandrinRobert Palau
Mar 29, 2008·Atherosclerosis·G R Thompson, UNKNOWN HEART-UK LDL Apheresis Working Group
Sep 26, 2012·Clinical Research in Cardiology Supplements·Peter Schuff-WernerPeter Kohlschein
Aug 21, 2013·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Jul 24, 2014·European Heart Journal·Marina CuchelUNKNOWN European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia
Aug 1, 2015·Journal of Clinical Lipidology·Jeanine Roeters van LennepRodrigo Alonso
May 14, 2016·Journal of Atherosclerosis and Thrombosis·Genovefa D KolovouGerald F Watts
Sep 1, 2016·Journal of Clinical Lipidology·Claudia StefanuttiAlberto Grossi
Mar 4, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Xin LiuGeorge Liu
Apr 23, 2017·Advances in Therapy·Laura D'ErasmoMarcello Arca
Jul 19, 2017·Circulation·Dirk J BlomMarina Cuchel